Ontology highlight
ABSTRACT:
SUBMITTER: Kaufman PA
PROVIDER: S-EPMC4463422 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
Kaufman Peter A PA Awada Ahmad A Twelves Chris C Yelle Louise L Perez Edith A EA Velikova Galina G Olivo Martin S MS He Yi Y Dutcus Corina E CE Cortes Javier J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20150120 6
<h4>Purpose</h4>This phase III randomized trial (ClinicalTrials.gov identifier: NCT00337103) compared eribulin with capecitabine in patients with locally advanced or metastatic breast cancer (MBC).<h4>Patients and methods</h4>Women with MBC who had received prior anthracycline- and taxane-based therapy were randomly assigned to receive eribulin or capecitabine as their first-, second-, or third-line chemotherapy for advanced/metastatic disease. Stratification factors were human epidermal growth ...[more]